GENITOURINARY OR UROGENTICAL SYNDROME: POSSIBILITIES OF LONG-TERM THERAPY
https://doi.org/10.21518/2079-701X-2016-12-98-101
Abstract
The article presents a review of the literature, reflecting the modern aspects of the terminology, classification, pathogenesis, and treatment options of urogenital disorders in women during menopause. This article shows the sensitivity of the lower parts of the urogenital tract to sex steroids, whose importance in the genesis of vaginal and urinary symptoms is not in doubt. These questions about effectiveness of systemic and local hormone replacement therapy and various schemes of treatment regimens was investigated by many scientists in this article.
About the Authors
V. E. BalanRussian Federation
MD, Prof.
L. A. Kovaleva
Russian Federation
PhD in medicine
E. V. Tikhomirova
Russian Federation
PhD in medicine
References
1. Сухих Г.Т., Сметник В.П., Андреева Е.В., Балан В.Е. и соавт. Менопаузальная гормонотерапия и сохранение здоровья женщин в зрелом возрасте. Клинические рекомендации (Протокол лечения). Москва, 2015. / Sukhih G.T., Smetnik V.P., Andreeva E.V., Balan V.E. et al. Menopausal hormone therapy and health maintenance in women of middle age. Clinical recommendations (Therapeutic Protocol). Moscow, 2015.
2. Балан В.Е., Сметник В.П., Анкирская А.С. и соавт. Урогенитальные расстройства в климактерии. В кн. «Медицина климактерия» под ред. Сметник В.П. ООО «Издательство Литера» 2006; С. 21790./Balan V.E., Smetnik V.P., Ankirskaya A.S. et al. Urogenital disturbances and menopauses. In the book Medicine of Menopause ed. by Smetnik V.P. LLC Publishing House Litera 2006; P.217-90.
3. Al-Baghdadi O., A.A, Ewies Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric. 2009; P. 91-105.
4. Barlow D.H., Cardozo L.D., Francis R.M. et al. Urogenital ageing and its effect on sexual health in older British women. Br. J. Obstet. Gynaecol. 1997. – 104. – P. 87-91.
5. Calleja-Agius J., Brincat M.P. Urogenital atrophy. Climacteric. 2009; 12: P. 279-85.
6. Estrogen and progestogen use in postmenopausal women: position statement of The North American Menopause Society. Journal of The North American Menopause Society. 2008; 4: P. 584-603.
7. Gebhardt J., Richard D., Barrett T. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am. J. Obstet. Gynecol. 2001; P. 1325-30.
8. Cavallini, E. Dinaro, A. Giocolano et all. Estrogen receptor (ER) and ER-related receptor expressoin in normal and atrophic human vagina. Maturitas. 2008; P. 219-25.
9. Raghunandan C., Agrawal S., Dubey P. et al. A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J. Sex Med. 2010; P. 1284-90.
10. AlBaghdadi O., Ewies A.A. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric. 2009 Apr; 12(2):91-105.].
11. Santen R.J. et al. Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21. Review. [PMID: 20566620].
12. Юренева С.В., Ермакова Е.И., Глазунова А.В. Диагностика и терапия генитоуринарного менопаузального синдрома у пациенток в перии постменопаузе (краткие клинические рекомендации). Акушерство и гинекология. 2016; 5: 138-144./Yureneva S.V., Ermakova E.I., Glazunova A.V. Diagnostics and therapy of genitourinary menopausal syndrome in patients in periand postmenopause (short clinical recommendations). Akusherstvo I Ginekologia.2016; 5: 138-144.
13. Сметник В.П. Генитоуринарный менопаузальный синдром: новый термин, обоснование и дискуссия. Акушерство и гинекология. 2016; 4: 7-10./Smetnik V.P. Genitourinary menopausal syndrome: a new term, justification and discussion. Akusherstvo I Ginekologia. 2016; 4: 7-10.
Review
For citations:
Balan VE, Kovaleva LA, Tikhomirova EV. GENITOURINARY OR UROGENTICAL SYNDROME: POSSIBILITIES OF LONG-TERM THERAPY. Meditsinskiy sovet = Medical Council. 2016;(12):98-101. (In Russ.) https://doi.org/10.21518/2079-701X-2016-12-98-101